1. Preliminary
The first activity for publishing a technical paper is to figure out your technical area of interest. Make sure the you had carried out enough studies on basics of that topic. Then you have you to update yourself with the ongoing technical happenings in your chosen field. You can do this by
1) Reading and googling a lot of technical papers. There are a lot of journals and IEEE papers floating around in net.
2) Go to one or more conferences, listen carefully to the best talks, and find out what people are thinking about.
Once you are done with the above mentioned steps, then you are eligible for writing a paper
2. Read existing Papers
Read everything that might be relevant gives you different perspective of the focus topic. But be selective too, for not getting to much deviated from you topic of interest. Getting used to simulation software is much useful for simulating your work. You can find a lot of time during the days and utilize those holidays & free days.
3. A jump start
When you first start reading up on a new field, ask your fellow researcher what the most useful journals and conference proceedings are in your field, and ask for a list of important papers that you should read. This activity will give you a jump start.
4. Crack the jargons and terms
One of among the tough nuts to crack is to understand the paper published by others. The easiest way is to is by reading it many times. The more times you read the more will be revealed to you. Keep the Internet handy so that you can crack the jargons and terms, which you may find strange.
5. Write down your studies
Write down speculations, interesting problems, possible solutions, random ideas, references to look up, notes on papers you've read, outlines of papers to write, and interesting quotes. Read back through it periodically. Keeping a journal of your research activities and ideas is very useful.
7. Bits and pieces together
Now you can identify important open problems in your research field and also you will be very much aware of what you are doing and what you have to do. The more you go, you'll notice that the bits of random thoughts start to come together and form a pattern, which may be a bright enough for a good paper.
8. Simulation softwares easies
Please don't pick overly ambitious topics; instead identify a realistic size problem. Gather the Matlab files available in the Internet that is related to your topic and simulate it for the claimed results. Please don’t expect the Mfiles readily available for a solution published in a paper. But you can make it of your own by modifying and adding. Believe me, Matlab is a very easy tool! Once you are able to get the simulated outputs of your solution, you can carry on for making a paper out of it.
9. Essence of your work
The essence of your work can be diagnosed by analyzing below listed points. We can increase the maturity of the paper by improving these.
Significance: Why was this work done? Did you solve an important problem of current interest or is it an obscure or obsolete problem?
Originality/Novelty: Is your approach novel or is it tried-and-true? Did you need to develop new tools, either analytical or physical?
Completeness: Have you tested a wide range of scenarios, or is this just a simple proof-of-concept?
Correct: Is your solution technically sound or are there errors? [3]
Consider improving the same.
10. Anatomy of Paper
Generally a paper has seven sections and a maximum of four pages. They are
1. Abstract,
2. Introduction,
3. Existing techniques,
4. Your contribution,
5. Results and
6. Conclusion.
11. The procedure
As a part of your paper publication, you can start documenting the ‘existing techniques’ from the scrap journal you did during the studies. Here you have to extract what all are the techniques existing as a solution for the particular problem and the pros and cons of those.
Next, document the 'introduction' about what is the topic and what you are going to do. Better to keep it short. Follows your contribution and the simulated results.
1. Describe the problem
2. State your contributions
"Abstract" is one section you can work on in the last, as it has to cover the all the sections very briefly. Please note that Abstract makes the committee members to decide whether or not to read your paper. Generally four lines are sufficient for this.
1. State the problem
2. Say why it's an interesting problem
3. Say what your solution achieves
4. Say what follows from your solution
12. Section by section
The divide-and-conquer strategy works on a day-to-day level as well. Instead of writing an entire paper, focus on the goal of writing a section, or outline. Remember, every task you complete gets you closer to finishing your paper.
13. Get a pre-review
Now your paper is ready. You can ask your peers or professors to review your paper. Next is to find the right place to publish it. You can start of with national level conferences, which often gets conducted in many universities. Then once you gain a level of confidence, you can proceed to international conferences and journals.
14. Read the reviews carefully
This is really, really, really hard. Only a small proportion, 5 to 10 percent, are accepted the first time they are submitted, and usually they are only accepted subject to revision. In fact, anything aside from simply "reject," Neal-Barnett reminds, is a positive review. These include:
* Accept: "Which almost nobody gets," she says.
* Accept with revision: "Just make some minor changes."
* Revise and resubmit: "They're still interested in you!"
* Reject and resubmit: Though not as good as revise and resubmit, "they still want the paper!"[2]
Read every criticism as a positive suggestion for something you could explain more clearly
15. Don't panic
After reading the review the first time, put it aside. Come back to it later, reading the paper closely to decide whether the criticisms were valid and how you can address them. You will often find that reviewers make criticisms that are off-target because they misinterpreted some aspect of your paper. If so, don't let it get to you -- just rewrite that part of your paper more clearly so that the same misunderstanding won't happen again.
It's frustrating to have a paper rejected because of a misunderstanding, but at least it's something you can fix. On the other hand, criticisms of the content of the paper may require more substantial revisions -- rethinking your ideas, running more tests, or redoing an analysis.
16. Rejected? Be Positive
If your paper is rejected, keep trying! Take the reviews to heart and try to rewrite the paper, addressing the reviewer's comments. "Remember, to get a lot of publications, you also will need to get lots of rejections," says Edward Diener, PhD, editor of APA's Journal of Personality and Social Psychology: Personality Processes and Individual Differences.
17. Common mistakes
Wrong sequence in Figure and Table numbering
Misalignment of columns
Usage of figures from another paper without credit and permission
18. Where to publish
Generally, there are three main choices:
* National Conference: A conference is the right place for beginner scholars, since the level of scrutiny is minimal. The conferences will accept papers which details about the comparison of existing technologies, mathematically proven but practically unproven proposals, etc.
* International Conference: A conference is the good play ground for Intermediated scholars. This mostly same as National Conference but the securitization will be more.
Conferences offer rapid time-to-publish, plus you will often get feedback on your work when you present it.
Page lengths and acceptance standards vary widely from conference to conference, but generally conference papers are shorter than full journal papers. [3]
* Journal: Journal papers are generally the Alfa and Omega of publishing papers and they are considered as more prestigious than conferences.
Register Sign in
Register or sign-in in order to manage your journal lists
Sign in or register to save a journal
To save a journal and create lists, you need to sign in to your Elsevier account.
Find the right journal for your research
Looking for the best journal match for your paper? Search the world's leading source of academic journals using your abstract or your keywords and other details.
Check if you're eligible for open access (OA) savings.
Free journals by Subjects
- Agricultural and Biological Sciences
- Anthropology
- Artificial Intelligence
- Arts and Humanities
- Biochemistry, Genetics and Molecular Biology
- Biomedical Engineering
- Biotechnology
- Business, Management and Accounting
- Chemical Engineering
- Civil and Structural Engineering
- Computational Mechanics
- Computer Science
- Decision Sciences
- Dermatology
- Earth and Planetary Sciences
- Economics, Econometrics and Finance
- Electrical and Electronic Engineering
- Epidemiology
- Engineering
- English Literature
- Environmental Science
- Geography, Planning and Development
- Health Professions
- Horticulture
- Immunology and Microbiology
- Linguistics and Language
- Machine Learning
- Materials Science
- Mathematics
- Mechanical Engineering
- Multidisciplinary
- Neuroscience
- Pharmacology, Toxicology and Pharmaceutics
- Physics and Astronomy
- Physiotherapy
- Political Science and International Relations
- Public Administration
- Social Sciences
- Statistics and Probability
List of free publication journals indexed in Scopus, SCI
This web page aims to provide the latest list of free publication research journals. These journals are Web of Science and Scopus indexed. Moreover, all these scientific journals are open access . Researchers are advised to click on the journal title to know more journal details.
Free publication journalsS. No. | Journal Title | Publisher | ISSN | Review Process |
---|
1 | | SAGE Publishing | 0256-0909 | Double anonymous peer review |
2 | | Springer | 0043-6275 | Anonymous peer review |
3 | | Elsevier | 0370-2693 | Peer review |
4 | | SpringerOpen | 0378-603X | Double anonymous peer review |
5 | | SpringerOpen | | Double anonymous peer review |
6 | | SpringerOpen | | Double anonymous peer review |
7 | | Elsevier | 0716-8640 | Double anonymous peer review |
8 | | SpringerOpen | | Anonymous peer review |
9 | | SpringerOpen | 2095-087X | Peer review |
10 | | SAGE Publishing | 1879-3665 | Double anonymous peer review |
11 | | SpringerOpen | 1110-0362 | Double anonymous peer review |
12 | | SpringerOpen | 1110-2608 | Double anonymous peer review |
13 | | SpringerOpen | 1110-1768 | Double anonymous peer review |
14 | | SpringerOpen | 1110-8630 | Double anonymous peer review |
15 | | SpringerOpen | 1110-5690 | Anonymous peer review |
16 | | SpringerOpen | 1110-5704 | Double anonymous peer review |
17 | | SpringerOpen | 1110-6611 | Double anonymous peer review |
18 | | SpringerOpen | 1110-6638 | Double anonymous peer review |
19 | | SpringerOpen | | Anonymous peer review |
20 | | SpringerOpen | 2090-536X | Double anonymous peer review |
21 | | Elsevier | | Anonymous peer review |
22 | | SAGE Publishing | | Anonymous peer review |
23 | | Elsevier | 1516-8484 | Double anonymous peer review |
24 | | SpringerOpen | 2090-9896 | Anonymous peer review |
25 | | SpringerOpen | | Anonymous peer review |
26 | | SAGE Publishing | 2096-5311 | Double anonymous peer review |
27 | | SpringerOpen | 2314-7202 | Double anonymous peer review |
28 | | SAGE Publishing | 1868-1026 | Double anonymous peer review |
29 | | SpringerOpen | | Anonymous peer review |
30 | | SpringerOpen | | Anonymous peer review |
31 | | SpringerOpen | | Double anonymous peer review |
32 | | SpringerOpen | 2090-5408 | Anonymous peer review |
33 | | SpringerOpen | | Double anonymous peer review |
34 | | SpringerOpen | | Double anonymous peer review |
35 | | Springer | | Double anonymous peer review |
36 | | Elsevier | 1695-4033 | Double anonymous peer review |
37 | | Elsevier | | Double anonymous peer review |
38 | | SAGE Publishing | | Anonymous peer review |
39 | | SAGE Publishing | 2515-1355 | Anonymous peer review |
40 | | SpringerOpen | 2314-7245 | Double anonymous peer review |
41 | | SAGE Publishing | 2010-1058 | Double anonymous peer review |
42 | | SAGE Publishing | 2631-8318 | Double anonymous peer review |
43 | | Elsevier | | Anonymous peer review |
44 | | SAGE Publishing | 2212-585X | Anonymous peer review |
45 | | SpringerOpen | | Anonymous peer review |
46 | | SAGE Publishing | | Double anonymous peer review |
47 | | SAGE Publishing | 1866-802X | Double anonymous peer review |
48 | | SAGE Publishing | 2210-4917 | Double anonymous peer review |
49 | | SpringerOpen | 2314-8535 | Double anonymous peer review |
50 | | SAGE Publishing | 1868-1034 | Double anonymous peer review |
51 | | Springer | | Double anonymous peer review |
52 | | SAGE Publishing | | Double anonymous peer review |
53 | | SAGE Publishing | 1569-1861 | Double anonymous peer review |
54 | | Elsevier | 0019-4832 | Double anonymous peer review |
55 | | SAGE Publishing | 0253-7176 | Double anonymous peer review |
56 | | Springer | 1976-6912 | Anonymous peer review |
57 | | SpringerOpen | | Anonymous peer review |
58 | | SAGE Publishing | | Anonymous peer review |
59 | | SpringerOpen | | Anonymous peer review |
60 | | SAGE Publishing | | Anonymous peer review |
61 | | Springer | | Anonymous peer review |
62 | | Springer | | Anonymous peer review |
63 | | Elsevier | | Anonymous peer review |
64 | | Springer | | Double anonymous peer review |
65 | | Springer | | Anonymous peer review |
66 | | SpringerOpen | 2097-1419 | Anonymous peer review |
67 | | Springer | | Double anonymous peer review |
68 | | SAGE Publishing | | Double anonymous peer review |
69 | | SpringerOpen | | Anonymous peer review |
70 | | SpringerOpen | 2662-9291 | Anonymous peer review |
71 | | Elsevier | 1882-7616 | Double anonymous peer review |
72 | | SpringerOpen | 2662-4745 | Anonymous peer review |
73 | | SpringerOpen | | Anonymous peer review |
74 | | Springer | | Anonymous peer review |
75 | | Springer | | Double anonymous peer review |
76 | | Springer | | Anonymous peer review |
77 | | SpringerOpen | | Double anonymous peer review |
78 | | SpringerOpen | 2096-3041 | Double anonymous peer review |
79 | | SpringerOpen | 1110-1903 | Anonymous peer review |
80 | | Elsevier | 1008-1275 | Anonymous peer review |
81 | | SpringerOpen | 2095-8293 | Double anonymous peer review |
82 | | SpringerOpen | 2096-0433 | Peer review |
83 | | SpringerOpen | 1434-6044 | Anonymous peer review |
84 | | SpringerOpen | | Anonymous peer review |
85 | | SpringerOpen | | Anonymous peer review |
86 | | Elsevier | 1674-2370 | Double anonymous peer review |
87 | | Elsevier | | Anonymous peer review |
88 | | SAGE Publishing | 0301-5742 | Double anonymous peer review |
89 | | SpringerOpen | 2223-7690 | Anonymous peer review |
90 | | SpringerOpen | 2199-6687 | Double anonymous peer review |
91 | | Springer | 2788-8614 | Anonymous peer review |
92 | | Springer | | Anonymous peer review |
93 | | Elsevier | | Double anonymous peer review |
94 | | SpringerOpen | 1687-8426 | Anonymous peer review |
95 | | Elsevier | 1135-2523 | Double anonymous peer review |
96 | | Springer | | Anonymous peer review |
97 | | SpringerOpen | | Anonymous peer review |
98 | | SAGE Publishing | 1747-0161 | Double anonymous peer review |
99 | | SpringerOpen | | Anonymous peer review |
100 | | Springer | | Double anonymous peer review |
101 | | Elsevier | 2211-3835 | Anonymous peer review |
102 | | Elsevier | 1738-5733 | Anonymous peer review |
103 | | Elsevier | 1674-7755 | Anonymous peer review |
104 | | Elsevier | 1672-2930 | Anonymous peer review |
105 | | Elsevier | 1672-6308 | Double anonymous peer review |
106 | | Elsevier | 1818-0876 | Anonymous peer review |
107 | | Elsevier | 1836-9553 | Double anonymous peer review |
108 | | Elsevier | | Double anonymous peer review |
109 | | Elsevier | | Anonymous peer review |
110 | | Elsevier | | Anonymous peer review |
- Submit your COVID-19 Pandemic Research
- Research Leap Manual on Academic Writing
- Conduct Your Survey Easily
- Research Tools for Primary and Secondary Research
- Useful and Reliable Article Sources for Researchers
- Tips on writing a Research Paper
- Stuck on Your Thesis Statement?
- Out of the Box
- How to Organize the Format of Your Writing
- Argumentative Versus Persuasive. Comparing the 2 Types of Academic Writing Styles
- Very Quick Academic Writing Tips and Advices
- Top 4 Quick Useful Tips for Your Introduction
- Have You Chosen the Right Topic for Your Research Paper?
- Follow These Easy 8 Steps to Write an Effective Paper
- 7 Errors in your thesis statement
- How do I even Write an Academic Paper?
- Useful Tips for Successful Academic Writing
- Immigrant Entrepreneurship in Europe: Insights from a Bibliometric Analysis
- Enhancing Employee Job Performance Through Supportive Leadership, Diversity Management, and Employee Commitment: The Mediating Role of Affective Commitment
- Relationship Management in Sales – Presentation of a Model with Which Sales Employees Can Build Interpersonal Relationships with Customers
- Promoting Digital Technologies to Enhance Human Resource Progress in Banking
- Enhancing Customer Loyalty in the E-Food Industry: Examining Customer Perspectives on Lock-In Strategies
- Self-Disruption As A Strategy For Leveraging A Bank’s Sustainability During Disruptive Periods: A Perspective from the Caribbean Financial Institutions
- Chinese Direct Investments in Germany
- Evaluation of German Life Insurers Based on Published Solvency and Financial Condition Reports: An Alternative Model
- Slide Share
Guide for Authors
Authors-guidelines publish research paper in international journals
How to share your research article to increase the impact of your research
“ How to publish a paper in the Research Leap ”
Publishing guidelines for authors – The International Journal of Management Science and Business Administration – ISSN 1849-5664 (ONLINE) – ISSN 1849-5419 (PRINT)
The journal is submitted by clicking on the SUBMIT YOUR PAPER icon
– Click on the SUBMIT YOUR PAPER link which will take you through to the Journal Submission page
– Prepare your paper according to the Guide for Authors
– Submit your paper to our e-mail: ijmsba@researchleap.com
Open access
International Journal of Management Science and Business Administration articles are open-access, available to subscribers and public alike with the permission to reuse. There is no subscription fee to access the articles. The funding comes from the authors themselves.
The articles of the International Journal of Management Science and Business Administration are available free of charge both to individual users and organizations. This means users can read, download, copy, share, print out, or reference to the texts of the journal without having to get permission from the authors or publishers.
The fee for the open-access publication is paid either by authors themselves or their funder.
Payment process
The publication charge of International Journal of Management Science and Business Administration is 115 USD for online publication only or 175 USD for online publication + 2 hard copies. For additional copies, the charge is 15 USD per issue.
Direct payment using Paypal and credit cards can be made through the website. The detailed information on the payment process, including the bank transfer option, will be sent to the corresponding author email.
Review process
In the reviewing process, a paper is initially reviewed either by an editor or a co-editor. Next, if the editor/co-editor finds it suitable for publication, they send it to two other referees for peer-review. The review is double-blind peer review. Provided the referees approve the paper, the editor eventually has the final say about whether the article should be published as it is, amended, or rejected altogether.
It is of utmost importance that the articles for the journal have not been published before in the present or almost the same form, or they are being considered for publication in another journal. The journal can publish papers that were previously published in conference proceedings under the condition that the publication does not infringe upon the rights of the conference proceedings publisher. The authors of the paper must make sure that their work does not go against existing copyright as well as ensuring the paper will compensate for the publisher in case of a warranty breach. Unless agreed differently, the papers, as well as contributions, become the legal copyright of the journal so that the dispersion and proper use of them are facilitated. Authors should refer to ideas and findings of other authors of by proper citing of literature, referencing, such as using clear indented text or quotation marks and using APA style formatting.
Permissions
The requirements of our platform are as follows:
- The availability to reproduce the content or the chapter of a book
- Possibility of printing and electronic rights
- Global rights for the English language
- Possibility of material use for the life of the work without time restrictions on the material reuse
While using tables, charts or excerpts, exceeding four hundred words, from a different source, the followings must be taken into account.:
- Authors must get written permission from a third party copyright owner prior to using their texts, graphs or illustrations in their journal. Also, the permission must be cleared for small adaptations of any work written by another person.
- In case an author adapts a major part of the content, they must notify the copyright holder of the original paper in advance.
- Authors must get consent statements proof.
- Authors must refer to the source both in figure captions and acknowledge it in the list of reference.
Before using the content (even freely available online), authors must check the website for more details of the copyright owners as well as getting their permission.
- Authors ought not to submit their work to more than one journal. In the same way, they ought not to submit previously published works to the journal to be considered.
- Authors ought to guarantee the originality of their work while submitting. When they use words of others, proper citations must be provided. Plagiarism of any kind is considered unethical and accepted under no circumstances.
- In their papers, authors ought to demonstrate all the sources they have used as well as declaring any conflicts of interest.
- Due acknowledgements to all the contributors ought to be given in the research.
- In case of noticeable errors in the issued work, authors ought to immediately notify the editor of the journal and collaborate in the elimination/correction of them. In case a different party than the author informs the editor about the error, the author is obliged to write a retraction or make a correction through the medium of issuance.
Final submission of the research paper
It should be noted that prior to the publication, the proofs are not supplied. It is the journal which considers the final version of the paper. However, it is the responsibility of the author to check the article for completeness, grammatical, spelling, and typographical errors. publish research paper in international journals
File formats
Microsoft Word (DOC, DOCX) is suitable for the final manuscript document.
Manuscript/Paper requirements
All the manuscripts submitted to Research Leap must be split into the sections in the following order: Make sure you use the following guidelines while preparing your manuscript for submission:
| It is imperative that all the files are submitted as a Word document |
| Including the references and appendices, the articles must be no fewer than 3000 words but not exceed 9000. |
| The title should not exceed ten words in total |
| Using a special template, an Article Title Page ought to be submitted together with the article. The template should include the following: § Title of the article § Details of the author (see below) § Acknowledgements § Biographies of authors § Structured Abstract (see below) § Keywords (see below) § Classification of the article |
| The Article Title Page must include the followings: |
| An author should provide an abstract on the Article Title Page containing: § The objective (mandatory) § Design/methodology/approach (mandatory) § Outcomes (mandatory) § Limitations and implications of the research (optional) § Practical implications (optional) § Social implications (optional) § Originality or/and value (mandatory) Including keywords and article classifications, the word count should not exceed 300. |
| The Article Title Page should contain no more than ten keywords recapping the main topics of the research. Although the editorial team of the journal will try to keep the keywords in the publication, those might be changed or replaced with different terms to ensure consistency. |
| Authors must ensure their paper on the Article Title Page falls under one of the following categories: § Empirical study § Hypotheses and theory § Case study § Literature review. |
| Conciseness of the headings must be ensured with clear differentiation between the order of headings. Ideally, the first level headings are written in bold format and sub-headings in medium italics. |
| When it is absolutely essential, notes or endnotes might be used, being demonstrated in the text by consecutive numbers, in square brackets, and illustrated at the end of the paper. |
| In the acknowledgement section, authors must declare the sources of outer research funding with a statement. The role of the funder/financial sponsor must be described from the beginning of the study design to submission, |
| All the figures, including graphs, diagrams, web pages, and photographic images, ought to be submitted in an electronic form. Quality and legibility of the figures must be ensured with being numbered in order with Arabic numerals. In order to ease the appearance of the graphics on the online database, they might be provided in color. § All figures made in MS Word, MS PowerPoint, MS Excel have to be provided in their original form. If the figures are created in other formats, they must be copied and pasted into a new MS Word page or saved and then imported into an MS Word document. Alternatively, a .pdf format can be created from the software of origination. § In case the figures cannot be provided in the above-mentioned formats, they can be accepted in .pdf, .ai, and .eps. Again, if these formats are impossible to use, then you can submit the figures in tif, .jpeg, or .bmp at a minimum of 10cm wide and a resolution of 300dpi. § While preparing web pages or screenshots, screenshot the image and paste it into a new Microsoft Word page using the “Alt” + “Print Screen” (or “Ctrl” + “Print Screen” if you want to screenshot all the contents of the screen) and “Ctrl”+”V.” The photographic images have to be saved as .tif or .jpeg files of at least 10cm wide and at a resolution of minimum 300dpi. They also ought to be supplied in an electronic form with high quality. To ensure that, you can set your camera settings at the highest quality and resolution. |
| When tables are used, they should be clearly labeled in the text body with the labels as legible as possible. In addition, superscripts and asterisks must be illustrated next to the items they refer to and have corresponding descriptions illustrated as footnotes. |
| In order to enable the readers to use Reference Linking facility on the database and refer back to the cited works via CrossRef, your references have to be in APA style written completely, accurately, and consistently. Cited texts should be in the following forms: § Using the first-named author’s name: § Using two names: § When there are more than two authors: You must use a reference list at the end of your paper in alphabetical order. |
| Surname, Initials (year), , Place of publication, Publisher.e.g. Barney, J. B., & Hesterly, W. S. (2010). (pp. 4-25). Upper Saddle River, NJ: Prentice Hall. |
| Surname, Initials (year), Chapter title, In Editor’s Initials, Surname, , Publisher, pp. pages of chapter, Publisher, e.g. Calabrese, F. A. (2005). The early pathways: Theory to practice—A continuum. In (pp. 15-50). Butterworth-Heinemann. |
| Surname, Initials (year), Title of article, , volume, number, pages.e.g. Bekmurodova, G. (2020). Theoretical Features of FDI (Foreign Direct Investment) and its Influence to Economic Growth. , (2), 33-39. |
| Surname, Initials (year of publication), Title of paper, in , volume, (pp. page number). Publisher, Place of Publication e.g. Weinstein, A., & Pohlman, R. A. (2015). Customer value: a new paradigm for marketing management. In (pp. 132-133). Springer, Cham. |
| Surname, Initials (year). Title of paper, paper presented at , , available at: URL if freely available on the internet (accessed date).e.g. Aumueller, D. (2005, May). Semantic authoring and retrieval within a Wiki. In ., available at: (accessed 20 February 2007). |
| Surname, Initials (year). . working paper [number if available], Institution or organization, Place of organization, date e.g. Moizer, P. (2003). . working paper, Leeds University Business School, University of Leeds, Leeds, 28 March. |
| Editor, A., & Editor, B. (Eds.). (Date). Dictionary/Encyclopedia entry. In (edition, if not the first). Publisher. e.g. Hughes, J. M., Michell P. A., & Ransom, W. S. (Eds.). (1992). Zucchini. In (2nd ed.). Oxford University Press. |
| Surname, Initials. (date). Article title. , pages. e.g. Smith, A. (January 21, 2008). Money for old rope. , pp. 1, 3-4. |
| (date). , pages. e.g. Small change , p. 7. |
| If available online, the full URL should be supplied at the end of the reference, as well as a date that the resource was accessed.e.g. Castle, B. (2005). . Name of the Website, available at: (accessed 12 November 2007).Standalone URLs, i.e. without an author or date, should be included either within parentheses within the main text, or preferably set as a note (roman numeral within square brackets within text followed by the full URL address at the end of the paper). |
Research Leap Policy
The editor of journals of Research Leap platform is solely responsible for deciding which articles submitted to the journal shall be published. To reach this decision, the editor is guided by policies of the journal’s editorial board and constrained by such legal requirements in force regarding libel, copyright infringement, and plagiarism. Published articles should remain extant, exact and unaltered as far as is possible. However, there may arise some occasional circumstances when published article must be later retracted or even removed. All these actions mentioned above can take place under exceptional circumstances.
Crossmark Policy
Crossmark is a multi-publisher initiative from Crossref to provide a standard way for readers to locate the current version of a piece of content. By applying the Crossmark logo, Research Leap is committing to maintaining the content it publishes, and to alerting readers to changes if and when they occur.
Clicking on the Crossmark logo will tell you the current status of a document, and may also give you additional publication record information about the document.
Article Withdrawal
Article withdrawal is only applicable for articles which were previously published in the other journals or accidently submitted twice. In most cases, articles may represent serious issues including infringements of professional ethical codes, such as multiple submission, plagiarism, and fraud usage of data. The withdrawal process is also applicable to articles which are in press (under consideration to be published in the other journals) that has different errors, or duplications of articles published in other journals are considered to be “withdrawn” from Research Leap. Withdrawn indicates that content of articles such as HTML and PDF is removed and replaced with HTML page and PDF simply mentioning that the article has been withdrawn according to Research Leap Policy on Article in Press Withdrawal with a link to the current policy document.
Article Retraction
Infringement of academic and professional ethical codes includes multiple submission, plagiarism, fraudulent use of data. The retraction will be mainly used to correct publication and submission errors. Retraction of an article will be done by the author or the editor based on the advice of members of the scholarly community. Number of scholarly bodies has developed the standards dealing with retractions, and best of these retractions are adopted for article retraction by Research Leap:
- A retraction note titled “Retraction: [article title]” signed by the authors and/or the editor is published in the paginated part of a subsequent issue of the journal and listed in the contents list.
- In the electronic version, a link is made to the original article.
- The online article is preceded by a screen containing the retraction note. It is to this screen that the link resolves; the reader can then proceed to the article itself.
- The original article is retained unchanged save for a watermark on the .pdf indicating on each page that it is “retracted.”
- The HTML version of the document is removed.
Article Removal: Legal limitations
It may be required to remove an article from the online database only in the extremely limited number of cases. This type of article removal will occur under the following circumstances:
- The article is clearly defamatory
- Infringes other’s legal rights
- The article poses serious health risk
- Breaking terms and conditions of publishing by the author
In these cases, the article will be removed due to the legal reasons where only the information on metadata such as Title and Authors will remain. publish research paper in international journals
Article Replacement
When the article poses a severe health risk, the authors of the original article will be obliged to retract the flawed content and replace it with the corrected version. In these cases, the procedures for retraction will be followed with the difference that the database retraction will publish a link to the corrected re-published article and a history of the document. publish research paper in international journals
publish research paper in international journals
- UGC Approved Journals
- Editorial Board Member
- Reviewer Home
Understanding the Genetic and Evolutionary Basis of Lactase Persistence in Human Populations: A Comprehensive Review
Jintapong zuercher thammachai, shinnattapol songpholratchanon, pune phetra, kittanath limphotong, chananchida dussadeethommo, yadasiri rachatasitikul, kanat likittananan, phatchara tangtongchit, vathunya chudhakorn.
Abstract: Lactose intolerance is a prevalent condition characterized by the inability to digest lactose, a sugar in milk and dairy products, due to a deficiency in the lactase enzyme. This condition is influenced by genetic variations near the lactase gene (LCT), particularly single-nucleotide polymorphisms (SNPs) such as -13910 C>T and -22018 G>A, which are associated with lactase persistence. These genetic variants have undergone positive selection in populations with a history of dairy farming, such as Northern Europeans, some African, and Middle Eastern groups, allowing them to digest lactose into adulthood. The prevalence of lactose intolerance varies significantly across populations, with higher rates in groups without a history of dairy farming, such as Native Americans and East Asians. Symptoms include gastrointestinal complaints like bloating, gas, diarrhea, and abdominal pain following lactose consumption. The regulation of the LCT gene involves complex interactions with enhancer sequences and regulators like peroxisome proliferator-activated receptor gamma (PPARγ). Future treatments may include gene editing technologies and modulation of the gut microbiome. Understanding genetic and environmental factors can inform personalized nutrition recommendations and public health strategies, highlighting the dynamic interplay between genes and environment in lactose intolerance
Keywords: lactose intolerance, lactase persistence, LCT gene, genetic diagnosis, genetic variations, gene-environment interaction.
Title: Understanding the Genetic and Evolutionary Basis of Lactase Persistence in Human Populations: A Comprehensive Review
Author: Jintapong Zuercher Thammachai, Shinnattapol Songpholratchanon, Pune Phetra, Kittanath Limphotong, Chananchida Dussadeethommo, Yadasiri Rachatasitikul, Kanat Likittananan, Phatchara Tangtongchit, Vathunya Chudhakorn
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Vol. 12, Issue 1, April 2024 - September 2024
Page No: 114-128
Research Publish Journals
Website: www.researchpublish.com
Published Date: 02-September-2024
Information
Initiatives
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess .
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
- Active Journals
- Find a Journal
- Proceedings Series
- For Authors
- For Reviewers
- For Editors
- For Librarians
- For Publishers
- For Societies
- For Conference Organizers
- Open Access Policy
- Institutional Open Access Program
- Special Issues Guidelines
- Editorial Process
- Research and Publication Ethics
- Article Processing Charges
- Testimonials
- Preprints.org
- SciProfiles
- Encyclopedia
Article Menu
- Subscribe SciFeed
- Recommended Articles
- Google Scholar
- on Google Scholar
- Table of Contents
Find support for a specific problem in the support section of our website.
Please let us know what you think of our products and services.
Visit our dedicated information section to learn more about MDPI.
JSmol Viewer
The role of patient organizations in shaping research, health policies, and health services for rare genetic diseases: the dutch experience, 1. introduction, aims and objectives, 2. materials and methods, 2.1. key methods, 2.2. material, 3.1. the beginning—a father’s story, 3.2. challenges of living with a rare genetic disease: unmet needs and founding a parent/patient organization for neuromuscular diseases.
- Address the knowledge gap and the lack of informed care; provide appropriate, actionable education and information for parents about home care, transportation, technical help, financial help, and recreation; and organize support by setting up mutual help groups for different neuromuscular diseases;
- Promote needs-led research, cooperation, and active involvement in the field of research and in the development of therapies;
- Generate attention and publicity to reach all involved patients and parents and to find financial resources to support (V)SN’s activities.
3.2.1. (V)SN: Early Milestones and Achievements
- Implementing standing working groups to realize home visits for advice by an experienced member plus supplementing telephone consultation to fill home visit gaps;
- Organization of a special symposium aiming at the creation of a professional structural framework for (V)SN;
- Establishing a committee to raise attention for genetic muscular diseases in the medical and scientific communities;
- Organizing regular meetings with medical experts and researchers to facilitate members’ access to state-of-the-art information, to keep members informed and updated on current research projects and on latest research findings, and, last but not least, mentoring medical experts on patients’ needs and advocating needs-led research.
3.2.2. (V)SN Involvement in Orphan Drug Development
- Contacting and lobbying manufacturers to prepare for their assessment of cost-effectiveness and reimbursement procedures in The Netherlands;
- Lobbying the National Health Care Institute (Zorginstituut Nederland) [ 31 ] and the Ministry of Health (VWS) of The Netherlands [ 32 ];
- Educating physicians and researchers with respect to their role in the admission and reimbursement of orphan drugs. (V)SN is committed as well to the management of expectations of patients with regard to gene therapy.
3.2.3. (V)SN: Newborn Screening for Spinal Muscular Atrophy (SMA)
3.2.4. (v)sn today, 3.2.5. neuromuscular diseases internationally united, networking and partnering—from a patients’ initiative to pan-european research institutions: establishing the european alliance of neuromuscular disorders associations (eamda) and the european neuromuscular centre (enmc), 3.3. founding the first national patient umbrella organization for rgds in europe and shaping the infrastructure for genetic services and counseling centres in the netherlands, 3.3.1. shaping and implementing genetic service centres, including genetic counselling centres in the netherlands, 3.3.2. key steps taken by vsop to promote genetic counselling services and to raise public awareness about genetics.
- (i) Raising public awareness, addressing “genetic illiteracy”
- (ii) Capacity building for genetic services
3.3.3. National Umbrella Patient Organizations Internationally United and Partnering
- The development of educational material about next-generation sequencing (“Next generation sequencing in diagnostiek”) for the public, patients, and healthcare providers in collaboration with Erfocentrum [ 100 ];
- Joining of the supervisory board of H2O (Health Outcomes Observatory), a European project financed by both the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA) [ 101 ]. EFPIA represents the biopharmaceutical industry operating in Europe [ 102 ]. This project is intended to provide insight into clinical data and patient-reported data for patients from different disease areas and healthcare providers via dashboards, for example, for joint decision-making [ 103 ];
- Close involvement—through support to access to empirical data- in the document “Advice from the Health Council of The Netherlands” (Gezondheidsraad) to the government in November 2023 on preconception carrier screening. The Health Council recommends pilot research to determine whether preconception carrier screening could be responsibly offered to all prospective parents in The Netherlands to equip them with the information they need to enable them to make informed reproductive decisions [ 104 ];
- Co-ordinating the input of patients and patient organizations into the Clinical Genetics Knowledge Agenda, which describes the top 10 knowledge gaps in clinical genetic care. The two overarching knowledge questions are: what barriers are in place for healthy family members who are at increased risk of a hereditary condition with treatment options to be referred for genetic counselling and possibly DNA testing, and how can the identified barriers be overcome? The agenda was published at the end of 2022 [ 105 ]. The Netherlands Association of Clinical Geneticists (VKGN) is currently exploring the possibilities for further research to address these knowledge gaps, including input from the patient perspective.
- Participation in the decision-making process to add an NIPT (Non-Invasive Prenatal Test) in April 2023 as a standard option—if the pregnant woman wishes so—in the prenatal screening program of The Netherlands [ 106 ].
4. Where We Are Today, Future Prospects, and Challenges
4.1. challenges, 4.1.1. availability of treatment and costs of cell and gene therapies, 4.1.2. diagnostic odyssey and child mortality, 4.1.3. lack of diversity in genomics studies, 4.2. limitations, 5. epilogue and the lessons i learned, author contributions, institutional review board statement, informed consent statement, data availability statement, acknowledgments, conflicts of interest.
- Watson, J.D.; Crick, F.H.C. Molecular Structure of Nucleic Acids: A Structure of Deoxyribonucleic Acid. Nature 1953 , 171 , 737–738. [ Google Scholar ] [ CrossRef ]
- International HapMap Consortium. The International HapMap Project. Nature 2003 , 426 , 789–796. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- O’Brien, S.J. A decade of GigaScience: A perspective on conservation genetics. GigaScience 2022 , 11 , giac055. [ Google Scholar ] [ CrossRef ]
- McKusick, V. A New Discipline, A New Name, A New Journal. Genomics 1987 , 1 , 1–2. [ Google Scholar ] [ CrossRef ]
- Claussnitzer, M.; Cho, J.H.; Collins, R.; Cox, N.J.; Dermitzakis, E.T.; Hurles, M.E.; Kathiresan, S.; Kenny, E.E.; Lindgren, C.M.; MacArthur, D.G.; et al. A brief history of human disease genetics. Nature 2020 , 577 , 179–189. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- OMIM Gene Map Statistics, Updated 30 August 2024. Available online: https://omim.org/statistics/geneMap (accessed on 31 August 2024).
- OMIM. Available online: https://www.omim.org/statistics/paceGraph (accessed on 5 June 2024).
- Nguengang Wakap, S.; Lambert, D.M.; Olry, A.; Rodwell, C.; Gueydan, C.; Lanneau, V.; Murphy, D.; Le Cam, Y.; Rath, A. Estimating cumulative point prevalence of rare diseases: Analysis of the Orphanet database. Eur. J. Hum. Genet. 2020 , 28 , 165–173. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Muscular Dystrophy Association. Available online: https://www.mda.org (accessed on 5 June 2024).
- Cystic Fibrosis Association. Available online: https://www.cff.org (accessed on 5 June 2024).
- Bach, M.-A. Building the French Muscular Dystrophy Association: The Role of Doctor/Patient Interactions. Soc. Hist. Med. 1998 , 11 , 233–253. [ Google Scholar ] [ CrossRef ]
- Interview with Yann Le Cam: Reflecting on a Quarter Century as Chief Executive Officer, September 2023. Available online: https://www.eurordis.org/reflecting-on-a-quarter-century/ (accessed on 5 June 2024).
- De Knecht-van Eekelen, A. Erfelijkheid op de Agenda, Actualiteit van 25 jaar VSOP ; VSOP Alliantie voor Erfelijkheidsvraagstukken: Soestdijk, The Netherlands, 2004; pp. 19, 29, 49, 51, 53, 55, 57, 71–75, 94. Available online: https://vsop.nl/media/uploads/file/Erfelijkheid%20op%20de%20agenda%20-%20met%20hoofdstukken.pdf (accessed on 5 June 2024).
- Nishio, H.; Niba, E.T.E.; Saito, T.; Okamoto, K.; Takeshima, Y.; Awano, H. Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment. Int. J. Mol. Sci. 2023 , 24 , 11939. [ Google Scholar ] [ CrossRef ]
- Muscular Dystrophy, UK. Available online: https://www.musculardystrophyuk.org/ (accessed on 5 June 2024).
- Spierziekten Nederland. Available online: https://www.spierziekten.nl/overzicht/ (accessed on 5 June 2024).
- Orphanet Expert-Centres. Available online: https://www.orpha.net/en/expert-centres/network/483646 (accessed on 5 June 2024).
- Spierziekten Centrum Nederland. Available online: https://www.spierziektencentrum.nl/ (accessed on 5 June 2024).
- Official Journal of the European Union, 3.7.2009, C 151/7. Available online: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2009:151:0007:0010:EN:PDF (accessed on 5 June 2024).
- EUCERD. Recommendations on Quality Criteria for Centres of Expertise for Rare Diseases in Member States, 24 October 2011. Available online: http://www.rd-action.eu/eucerd/EUCERD_Recommendations/eucerd-recommendations(1).pdf (accessed on 5 June 2024).
- European Reference Network (ERN). Available online: https://health.ec.europa.eu/european-reference-networks_en (accessed on 5 June 2024).
- European Reference Network for Rare Neuromuscular Diseases. Available online: https://ern-euro-nmd.eu/ (accessed on 5 June 2024).
- European Patient Advocacy Groups (ePAGs) Essentials. Available online: https://www.eurordis.org/our-priorities/european-reference-networks/epag/epag/224 (accessed on 5 June 2024).
- Teresinha, E. Le réseau européen de référence pour les maladies neuromusculaires rares (EURO-NMD). De sa constitution à ses premiers pas. Médecine/Sciences 2019 , 35 , 51–54. Available online: https://www.medecinesciences.org/en/articles/medsci/pdf/2019/11/medsci190180s.pdf (accessed on 30 August 2024).
- Oosterwijk, C. Connecting Patient Organisations to Centres of Expertise by a Legal Role in the Designation Process. EURORDIS Membership Meeting 14 May 2021. Available online: https://download2.eurordis.org/EMM/EMM%202021/speaker%20presentations/EMM%202021_WS4_Cor%20Oosterwljilk.pdf (accessed on 5 June 2024).
- Prinses Beatrix Spierfonds. Available online: https://www.spierfonds.nl (accessed on 5 June 2024).
- van der Ploeg, A.T.; Reuser, A.J. Pompe’s disease. Lancet 2008 , 372 , 1342–1353. [ Google Scholar ] [ CrossRef ]
- IPA Conferences, Pompe’s Disease in Historical Perspective and the Way to Therapy, 30 November 1999. Available online: https://worldpompe.org/ipa-conferences/pompeas-disease-in-historical-perspective-and-the-way-to-therapy/ (accessed on 5 June 2024).
- High-Level Expertise in Pompe Disease. Available online: https://clmz.nl/en/pompe-center (accessed on 5 June 2024).
- Van den Brink, R. Reimbursement of orphan drugs: The Pompe and Fabry case in The Netherlands. Orphanet J. Rare Dis. 2014 , 9 (Suppl. S1), O17. Available online: http://www.ojrd.com/content/9/S1/O17 (accessed on 30 August 2024). [ CrossRef ]
- National Health Care Institute. Available online: https://english.zorginstituutnederland.nl/ (accessed on 5 June 2024).
- Government of The Netherlands, Ministry of Health, Welfare and Sport. Available online: https://www.government.nl/ministries/ministry-of-health-welfare-and-sport (accessed on 5 June 2024).
- Health Council of The Netherlands. Neonatal screening for spinal muscular atrophy. Available online: https://www.healthcouncil.nl/documents/advisory-reports/2019/07/23/neonatal-screening-for-spinal-muscular-atrophy (accessed on 1 August 2024).
- The Netherlands’ Zorginstituut (ZIN). Package Advice Package Lock Medicinal Product Onasemnogene Abeparvovec. (Zolgensma®) for the Treatment of SMA. Available online: https://english.zorginstituutnederland.nl/publications/reports/2021/05/06/package-advice-package-lock-medicinal-product-onasemnogene-abeparvovec-zolgensma (accessed on 1 August 2024).
- Kirschner, J.; Butoianu, N.; Goemans, C.; Haberlova, D.; Kostera-Pruszczyk, A.; Mercurig, E.; van der Pol, L.; Quijano-Roy, S.; Sejersen, T.; Tizzano, E.F.; et al. European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy. Eur. J. Paediatr. Neurol. 2020 , 28 , 38–43. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Zafeirio, D. Editorial Commentary: Gene therapy for spinal muscular atrophy: Solomon’s consensus in Covid times. Eur. J. Pediatr. Neurol. 2020 , 28 , 2–3. [ Google Scholar ] [ CrossRef ]
- Nuijten, M. Pricing Zolgensma—The world’s most expensive drug. J. Mark. Access Health Policy 2022 , 10 , 2022353. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Beneluxa Initiative on Pharmaceutical Policy. Available online: https://beneluxa.org/collaboration (accessed on 5 June 2024).
- Netherlands Kicks off Zolgensma Review for BeNeLuxA, Posted on 11 November 2020. Available online: https://www.eversana.com/2020/11/11/netherlands-kicks-off-zolgensma-review-for-beneluxa/ (accessed on 5 June 2024).
- National Health Care Institute, The Netherlands. Available online: https://www.zorginstituutnederland.nl/actueel/nieuws/2021/05/07/medicijn-zolgensma-voor-zeldzame-spierziekte-sma-alleen-in-basispakket-na-prijsonderhandeling (accessed on 5 June 2024).
- Outcome of Joint Negotiations for Zolgensma. 8 October 2021. Available online: https://beneluxa.org/statements#toc-08-october-2021-outcome-of-joint-negotiations-for-zolgensma (accessed on 5 June 2024).
- Atalaia, A.; Wandrei, D.; Lalout, N.; Thompson, R.; Tassoni, A.; Hoen, P.A.C.; Athanasiou, D.; Baker, S.-A.; Sakellariou, P.; Paliouras, G.; et al. EURO-NMD registry: Federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet J. Rare Dis. 2024 , 19 , 66. [ Google Scholar ] [ CrossRef ]
- Federation of European Myotonic Dystrophy Associations. Available online: https://euro-dyma.eu/member-organizations (accessed on 5 June 2024).
- Wouter, B.; Broekgaarden, R. The role of patient advocacy organisations in neuromuscular disease R&D—The case of the Dutch neuromuscular disease association VSN. Neuromuscul. Disord. 2010 , 20 , 148–151. [ Google Scholar ] [ CrossRef ]
- European Alliance of Neuromuscular Disorders Associations. Available online: http://www.eamda.eu/ (accessed on 5 June 2024).
- Vololona, R. The struggle against neuromuscular diseases in France and the emergence of the “partnership model” of patient organisation. Soc. Sci. Med. 2003 , 57 , 2127–2136. [ Google Scholar ] [ CrossRef ]
- European Neuromuscular Centre (ENMC). Available online: https://www.enmc.org/ (accessed on 5 June 2024).
- Emery, A. The European Neuromuscular Centre (ENMC): Importance of collaborative research. Neuromuscul. Disord. 1997 , 7 , 135–137. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Rüdel, R.; Nigro, G.; Poortman, Y. Ten years of ENMC from a patient’s initiative to a successful European research institution: The story of ENMC. Neuromuscul. Disord. 2000 , 10 , 75–82. [ Google Scholar ] [ CrossRef ]
- Emery, A.; Rutgers, M. European collaboration in research into rare diseases: Experience of the European Neuromuscular Centre. Clin. Med. 2001 , 1 , 200–202. [ Google Scholar ] [ CrossRef ]
- CWTS, B.V. Centre for Science and Technology Studies, Leiden University, September 2018 Bibliometric Research Performance of the European Neuromuscular Centre (ENMC) 2000–2016/17. Available online: https://www.enmc.org/wp-content/uploads/2019/04/ENMC_2000-2016-Final-Report-by-CWTS-Oct2018.pdf (accessed on 5 June 2024).
- Lochmüller, H.; Ambrosini, A.; van Engelen, B.; Hansson, M.; Tibben, A.; Breukel, A.; Sterrenburg, E.; Schrijvers, G.; Meijer, I.; Padberg, G.; et al. Meeting Report: The Position of Neuromuscular Patients in Shared Decision Making. Report from the 235th ENMC Workshop: Milan, Italy, 19–20 January 2018. J. Neuromuscul. Dis. 2019 , 6 , 161–172. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Breukel, A.; Willmann, R.; Padberg, G.; Sterrenburg, E.; Meijer, I. The impact of European Neuromuscular Centre (ENMC) workshops on the neuromuscular field; 25 years on …. Neuromuscul. Disord. 2019 , 29 , 330–340. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Ambrosini, A.; Quinlivan, R.; Sansone, V.A.; Meijer, I.; Schrijvers, G.; Tibben, A.; Padberg, G.; de Wit, M.; Sterrenburg, E.; Mejat, A.; et al. “Be an ambassador for change that you would like to see”: A call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease. Orphanet J. Rare Dis. 2019 , 14 , 126. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- SMA Europe. Available online: https://www.sma-europe.eu/ (accessed on 5 June 2024).
- Euro-Ataxia. Available online: https://www.euroataxia.org (accessed on 5 June 2024).
- Patient Alliance for Rare and Genetic Diseases. Available online: https://vsop.nl/english (accessed on 5 June 2024).
- Rodwell, C.; Aymé, S. (Eds.) 2014 Report on the State of the Art of Rare Disease Activities in Europe, July 2014., European Union, 2014.; p. 56, Figure 15: Countries in Europe with a National Alliance for Rare Disease Patient Organizations and Year Founded. Available online: http://www.eucerd.eu/upload/file/Reports/2014ReportStateofArtRDActivitiesV.pdf (accessed on 5 June 2024).
- Harper, P. Some pioneers of European human genetics. Eur. J. Hum. Genet. 2017 , 25 , 1–18. [ Google Scholar ] [ CrossRef ]
- Gezondheitsraad: Advies Inzake Genetic Counseling, Rijswijk 1977. Gezondheidsraad: Genetic Counseling. Den Haag, Gezondheidsraad, 1977; Publicatie nr. 77/14. Available online: https://www.nationaalarchief.nl/onderzoeken/archief/2.15.36 (accessed on 30 August 2024).
- Abacan, M.; Alsubaie, L.; Barlow-Stewart, K.; Caanen, B.; Cordier, C.; Courtney, E.; Davoine, E.; Edwards, J.; Elackatt, N.J.; Gardiner, K.; et al. The Global State of the Genetic Counseling Profession. Eur. J. Hum. Genet. 2019 , 27 , 183–197. [ Google Scholar ] [ CrossRef ]
- Hans Galjaard. Available online: https://www.ae-info.org/attach/User/Galjaard_Hans/CV/hans-galjaard-interview.pdf (accessed on 5 June 2024).
- Ten Kate, L.P. Community genetics in The Netherlands. In Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease ; Khoury, M.J., Burke, W., Thomson, E., Eds.; Oxford University: Oxford, UK, 2000; pp. 291–300. [ Google Scholar ] [ CrossRef ]
- De Smit, D.J. Information about Congenital Disorders: An Attempt to Improve Its Quality in Primary Care. Ph.D. Thesis, Research and Graduation Internal, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands, 1997. [ Google Scholar ]
- Baars, M.J.H.; A Scherpbier, A.J.J.; Schuwirth, L.W.; Henneman, L.; Beemer, F.A.; Cobben, J.M.; Hennekam, R.C.M.; Verweij, M.M.J.J.; Cornel, M.C.; Kate, L.P.T. Deficient knowledge of genetics relevant for daily practice among medical students nearing graduation. Genet. Med. 2005 , 7 , 295–301. [ Google Scholar ] [ CrossRef ]
- Poortman, E.A. Erfelijkheid en Ziekten ; De Fontain: Utrecht, The Netherlands, 1998; p. 16. [ Google Scholar ]
- Erfocentrum (Dutch National Genetic Resource and Information Centre). Available online: https://www.erfelijkheid.nl/content/over-ons (accessed on 5 June 2024).
- Poortman, Y. The European alliance of genetic support groups, their ethical code and the provision of genetic services. In The New Genetics: From Research into Health Care ; Nippert, I., Neitzel, H., Wolff, G., Eds.; Springer: Berlin/Heidelberg, Germany, 1999; pp. 125–130. Available online: https://link.springer.com/book/10.1007/978-3-642-58486-2 (accessed on 30 August 2024).
- Mikami, K. Citizens under the umbrella: Citizenship projects and the development of genetic umbrella organizations in the USA and the UK. New Genet. Soc. 2020 , 39 , 148–172. [ Google Scholar ] [ CrossRef ]
- European Genetic Alliances’ Network. Available online: https://egan.eu/contact/ (accessed on 5 June 2024).
- International Genetic Alliance. Available online: https://egan.eu/our-activities/international/iga/ (accessed on 5 June 2024).
- VSOP. Available online: https://vsop.nl/english/cooperation/ (accessed on 5 June 2024).
- The European Forum of Good Clinical Practice. Available online: https://efgcp.eu/ (accessed on 5 June 2024).
- The European Platform for Patient Organisations, Science and Industry. Available online: https://www.bionity.com/en/associations/37636/european-platform-for-patients-organisations-science-industry-epposi.htm (accessed on 5 June 2024).
- March of Dimes. Available online: https://www.marchofdimes.org (accessed on 5 June 2024).
- WAO. Available online: https://uia.org/s/or/en/1100035456 (accessed on 5 June 2024).
- EURORDIS—Rare Diseases Europe. Available online: https://www.eurordis.org/ (accessed on 5 June 2024).
- Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on Orphan Medicinal Products. Off. J. Eur. Communities 2000 , L18 , 1–5. Available online: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2000:018:0001:0005:en:PDF (accessed on 30 August 2024).
- Communicatiom from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions Rare Diseases: Europe’s challenges (2008). Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52008DC0679 (accessed on 5 June 2024).
- Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the Application of Patients’ Rights in Cross-Border Healthcare. Off. J. Eur. Communities . Available online: https://data.europa.eu/eli/dir/2011/24/oj (accessed on 30 August 2024).
- Aymé, S.; Rodwell, C. (Eds.) 2012 Report on the State of the Art of Rare Disease Activities in Europe of the European Union Committee of Experts on Rare Diseases; July 2012. Available online: https://www.eucerd.eu/upload/file/Reports/2012ReportStateofArtRDActivitiesV.PDF (accessed on 30 August 2024).
- The Solve-RD Project. Available online: https://solve-rd.eu/ (accessed on 5 June 2024).
- European Patient Advocacy Groups (ePAGs). Available online: https://www.eurordis.org/our-priorities/european-reference-networks/epag/epag/ (accessed on 5 June 2024).
- EURORDIS—Rare Diseases Europe. Available online: https://www.eurordis.org/publications/eurordis-recommendations-on-the-integration-of-european-reference-networks-erns-into-national-health-systems/ (accessed on 5 June 2024).
- Statement of the ERN Board of Member States on Integration of the European Reference Networks to the Healthcare Systems of Member States. Available online: https://health.ec.europa.eu/system/files/2019-07/integration_healthcaresystems_en_0.pdf (accessed on 5 June 2024).
- Available online: https://download2.eurordis.org/publications/One-Pager_JARDIN-Joint-Action.pdf (accessed on 5 June 2024).
- Integration of European Reference Networks and National Healthcare Systems—Minimum viable Product. Available online: https://www.eesc.europa.eu/sites/default/files/2024-03/graessner_-_jardin_eesc_session_1_holm_graessner.pdf (accessed on 5 June 2024).
- Rare 2030 Foresight in Rare Disease Policy. Available online: https://www.rare2030.eu/ (accessed on 5 June 2024).
- International Rare Diseases Research Consortium. Available online: https://irdirc.org/about-us/people-organisation/members-organizations/ (accessed on 5 June 2024).
- Boycott, K.M.; Rath, A.; Chong, J.X.; Hartley, T.; Alkuraya, F.S.; Baynam, G.; Brookes, A.J.; Brudno, M.; Carracedo, A.; Dunnen, J.T.D.; et al. International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases. Am. J. Hum. Genet. 2017 , 100 , 695–705. [ Google Scholar ] [ CrossRef ]
- First-Ever United Nations Resolution to Increase Visibility for the 300 Million Persons Living with a Rare Disease. Available online: http://download2.eurordis.org/pressreleases/EN_FINAL_International_PressRelease_UNResolution_EURORDIS.pdf (accessed on 5 June 2024).
- Report from the Inauguration of the NGO Committee for Rare Diseases. Available online: http://download2.eurordis.org.s3.amazonaws.com/ngocommittee/ngocommittee_report.pdf (accessed on 5 June 2024).
- NGO Committee for Rare Diseases. Available online: https://www.ngocommitteerarediseases.org/ (accessed on 5 June 2024).
- #30millionreasons for European on Rare Diseases. Available online: https://reasons.eurordis.org/ (accessed on 5 June 2024).
- Final Report Summary—PATIENTPARTNER (Identifying the Needs for Patients Partnering in Clinical Research). Available online: https://cordis.europa.eu/project/id/201720/reporting (accessed on 1 August 2024).
- European Patients’ Academy on Therapeutic Innovation. Available online: https://www.imi.europa.eu/projects-results/project-factsheets/eupati (accessed on 5 June 2024).
- EUPATIConnect. Available online: https://eupati.eu/ (accessed on 5 June 2024).
- Preparing for Life. Available online: https://preparingforlife.net/ (accessed on 5 June 2024).
- Preconception Care to Reduce Maternal and Childhood Mortality and Morbidity. Available online: https://www.who.int/publications/i/item/9789241505000 (accessed on 5 June 2024).
- Werk in Opdracht. Available online: https://www.erfocentrum.nl/over_ons/werk-opdracht (accessed on 5 June 2024).
- European Federation of Pharmaceutical Industries and Associations. Available online: https://www.efpia.eu/ (accessed on 5 June 2024).
- Capacity Building: How can Patient Organisations Shape the Future of Drug Development? Available online: https://www.efpia.eu/news-events/the-efpia-view/blog-articles/capacity-building-how-can-patient-organisations-shape-the-future-of-drug-development (accessed on 5 June 2024).
- Strengthening the Patient Voice in Health Care. Available online: https://health-outcomes-observatory.eu/ (accessed on 5 June 2024).
- Preconceptionele Dragerschapsscreening, Nr. 2023/18 Den Haag 15 November 2023. Available online: https://open.overheid.nl/documenten/c1bd9fbf-b747-4a75-b71a-c627c196a76f/file (accessed on 5 June 2024).
- VSOP, Jaarverslagen 2022. Available online: https://vsop.nl/over-ons/jaarverslagen (accessed on 5 June 2024).
- National Institute for Public Health and the Environment. Available online: https://www.rivm.nl/en/news/nipt-available-as-standard-option-for-all-pregnant-women-from-1-april (accessed on 5 June 2024).
- ZonMw—(The Netherlands Organisation for Health Research and Development). Available online: https://www.zonmw.nl/en/about-zonmw/international (accessed on 5 June 2024).
- Dutch Forum for Biotechnology and Genetics. Available online: https://www.forumbg.nl/dutch-forum-for-biotechnology-and-genetics/ (accessed on 5 June 2024).
- State of the Art for Rare Disease Activities in EU Member States and Other European Countries—Netherlands Report. Available online: http://www.rd-action.eu/wp-content/uploads/2017/10/Netherlands-Report-06.10.2017.pdf (accessed on 5 June 2024).
- Grody, W.W. The transformation of medical genetics by clinical genomics: Hubris meets humility. Genet. Med. 2019 , 9 , 1916–1926. [ Google Scholar ] [ CrossRef ]
- Braga, L.A.M.; Conte Filho, C.G.; Mota, F.B. Future of genetic therapies for rare genetic diseases: What to expect for the next 15 years? Ther. Adv. Rare Dis. 2022 , 3 , 26330040221100840. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Smith, C.I.E.; Bergman, P.; Hagey, D.W. Estimating the number of diseases—The concept of rare, ultra-rare, and hyper-rare. iScience 2022 , 25 , 104698. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Amaral, M.D. Precision medicine for rare diseases: The times they are A-Changin’. Curr. Opin. Pharmacol. 2022 , 63 , 102201. [ Google Scholar ] [ CrossRef ]
- Available online: https://www.weforum.org/agenda/2023/03/rare-diseases-changing-the-status-quo/ (accessed on 5 June 2024).
- Cost of Sequencing a Full Human Genome. Available online: https://ourworldindata.org/grapher/cost-of-sequencing-a-full-human-genome (accessed on 5 June 2024).
- Available online: https://www.wmbfnews.com/2024/04/30/newborn-twins-fight-rare-disease-family-says-itll-cost-42-million-save-their-lives/ (accessed on 5 June 2024).
- Sabatini, M.T.; Xia, T.; Chalmers, M. Pricing and Market Access Challenges in the Era of One-Time Administration Cell and Gene Therapies. Pharm. Med. 2022 , 36 , 265–274. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Smith, G. 20. März 2024, Bloomberg.com: World’s Most Expensive Drug Is Now $ 4.25 Million Gene Therapy. Available online: https://www.bloomberg.com/news/articles/2024-03-20/world-s-most-expensive-drug-is-now-4-25-million-gene-therapy (accessed on 5 June 2024).
- Sabatini, M.T.; Chalmers, M. The Cost of Biotech Innovation: Exploring Research and Development Costs of Cell and Gene Therapies. Pharm. Med. 2023 , 37 , 365–375. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Aartsma-Rus, A. Individualized ASO therapy for rare diseases. Commun. Med. 2023 , 3 , 27. [ Google Scholar ] [ CrossRef ]
- Editorial The gene-therapy revolution risks stalling if we don’t talk about drug pricing. Nature 2023 , 616 , 629–630. [ CrossRef ]
- Harrison, P.T.; Friedmann, T. Cost of gene therapy. Gene Ther. 2023 , 30 , 737. [ Google Scholar ] [ CrossRef ]
- Joffe, S.; Conti, R.M.; Contreras, J.L.; Largent, E.A.; Lynch, H.F.; Mitchell, D.; Sachs, R.E.; Whelan, A.M.; McCoy, M.S. Access to affordable medicines: Obligations of universities and academic medical centers. Gene Ther. 2023 , 30 , 753–755. [ Google Scholar ] [ CrossRef ]
- The Diagnostic Odyssey of People Living with a Rare Disease. Available online: https://www.eurordis.org/wp-content/uploads/2024/05/Diagnosis-printer-.pdf (accessed on 5 June 2024).
- Calcaterra, V.; Zuccotti, G. Non-Communicable Diseases and Rare Diseases: A Current and Future Public Health Challenge within Pediatrics. Children 2022 , 9 , 1491. [ Google Scholar ] [ CrossRef ]
- Gunne, E.; McGarvey, C.; Hamilton, K.; Treacy, E.; Lambert, D.M.; Lynch, S.A. Retrospective review of the contribution of rare diseases to paediatric mortality in Ireland. Orphanet J. Rare Dis. 2020 , 15 , 311. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Bavisetty, S.; Grody, W.W.; Yazdani, S. Emergence of pediatric rare diseases: Review of present policies and opportunities for improvement. Rare Dis. 2013 , 1 , e23579. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Fatumo, S.; Chikowore, T.; Choudhury, A.; Ayub, M.; Martin, A.R.; Kuchenbaecker, K. A roadmap to increase diversity in genomic studies. Nat. Med. 2022 , 28 , 243–250. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Popejoy, A.; Fullerton, S. Genomics is failing on diversity. Nature 2016 , 538 , 161–164. [ Google Scholar ] [ CrossRef ]
- World Economic Forum, World Scenario Series, The Future Role of Civil Society. January 2013. Available online: https://www3.weforum.org/docs/WEF_FutureRoleCivilSociety_Report_2013.pdf (accessed on 5 June 2024).
| The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Share and Cite
Poortman, Y.; Ens-Dokkum, M.; Nippert, I. The Role of Patient Organizations in Shaping Research, Health Policies, and Health Services for Rare Genetic Diseases: The Dutch Experience. Genes 2024 , 15 , 1162. https://doi.org/10.3390/genes15091162
Poortman Y, Ens-Dokkum M, Nippert I. The Role of Patient Organizations in Shaping Research, Health Policies, and Health Services for Rare Genetic Diseases: The Dutch Experience. Genes . 2024; 15(9):1162. https://doi.org/10.3390/genes15091162
Poortman, Ysbrand, Martina Ens-Dokkum, and Irmgard Nippert. 2024. "The Role of Patient Organizations in Shaping Research, Health Policies, and Health Services for Rare Genetic Diseases: The Dutch Experience" Genes 15, no. 9: 1162. https://doi.org/10.3390/genes15091162
Article Metrics
Further information, mdpi initiatives, follow mdpi.
Subscribe to receive issue release notifications and newsletters from MDPI journals
IMAGES
VIDEO
COMMENTS
Almost all publishers allow authors to publish for free. Below, you can check the list of journals that publish for free through the given link. List of Free Open Access Journals - 2023. Free (Non-Paid) Scopus Journals - 2023. Publish in Springer Journals without publication fee. You can also publish research papers in Springer for free.
Many free-to-publish and open-access journals and subscription journals from major publishers are "Free to author" by default. Some journals require an article processing charge (APC) but also have a policy allowing them to waive fees on request at the discretion of the editor. The Directory of Open Access Journals currently indexes 11,841 ...
Dear Nature,. I'm a paediatrician based in South Africa. Last year, my colleagues and I were invited to submit an editorial to a medical journal. We felt that the article, about medicine in ...
Publishing with SpringerOpen makes your work freely available online for everyone, immediately upon publication, and our high-level peer-review and production processes guarantee the quality and reliability of the work. Open access books are published by our Springer imprint. Find the right journal for you. Explore our subject areas.
Papers in these journals are published free of cost. ... Arts Research (STAR) Journal (ISSN: 2226-7522 (Print) and ISSN: 2305-3372 (Online)) is an international, open access, online, print, peer ...
4. Track your paper. 5. Share and promote. 1. Find a journal. Find out the journals that could be best suited for publishing your research. For a comprehensive list of Elsevier journals check our Journal Catalog. You can also match your manuscript using the JournalFinder tool, then learn more about each journal.
Scientific Journals with Open Access and No APC: In this blog post, we list 100 free open-access journals that publish research articles without any publication fee.. These journals are published by major publishers like Sage Publishing, Emerald Publishing, Springer Open, Elsevier, Taylor & Francis Group, Oxford University Press, and Open Library of Humanities.
About the directory. DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, and is committed to ensuring quality content is freely available online for everyone. DOAJ is committed to keeping its services free of charge, including being indexed, and its data freely available.
To Publish a Research Paper follow the guide below: Conduct original research: Conduct thorough research on a specific topic or problem. Collect data, analyze it, and draw conclusions based on your findings. Write the paper: Write a detailed paper describing your research.
Preparation. - Find the right journal for your manuscript. - The Springer Journal Selector. - Manuscript preparation (reference styles, artwork guidelines, etc.) Read more. - Electronic submission. - Reviewing and acceptance. - Managing copyright - The "MyPublication" process. - Copy editing and language polishing.
International history scholarly essays must be based on primary sources (archives, published primary source collections, oral histories, etc.). Submissions should be 6,000 to 8,000 words (inclusive of notes) and follow the journal's citation and style guide.
The introduction section should be approximately three to five paragraphs in length. Look at examples from your target journal to decide the appropriate length. This section should include the elements shown in Fig. 1. Begin with a general context, narrowing to the specific focus of the paper.
Ensure that your submission package is complete. Understand the submission process/system used for publishing in an international journal and find out whom to contact and how in case you have queries. Write a compelling cover letter. This document is probably the first submission item that a journal editor will read and can influence the fate ...
Make an impact and build your research profile in the open with ScienceOpen. Search and discover relevant research in over 95 million Open Access articles and article records; Share your expertise and get credit by publicly reviewing any article; Publish your poster or preprint and track usage and impact with article- and author-level metrics; Create a topical Collection to advance your ...
3. Submit your article according to the journal's submission guidelines. Go to the "author's guide" (or similar) on the journal's website to review its submission requirements. Once you are satisfied that your paper meets all of the guidelines, submit the paper through the appropriate channels.
Publishing a research paper immediately requires careful planning and swift execution. Select a Reputable Journal: Identify a journal that aligns with your research's scope and significance. Aim for well-regarded, peer-reviewed publications. Prepare Your Manuscript: Ensure your paper adheres to the journal's guidelines for formatting ...
Step 1: Choosing a journal. Choosing which journal to publish your research paper in is one of the most significant decisions you have to make as a researcher. Where you decide to submit your work can make a big difference to the reach and impact your research has. It's important to take your time to consider your options carefully and ...
Report results fully & honestly, as pre-specified. Text (story), Tables (evidence), Figures (highlights) Report primary outcomes first. Give confidence intervals for main results. Report essential summary statistics. Leave out non-essential tables and figures; these can be included as supplementary files. Don't start discussion here.
A list of free publishing Scopus indexed journals is provided. These Non paid Scopus journals don't charge APC from the authors. ... Publisher: International Journal of Mathematical, Engineering and Management Sciences. ISSN No.: 24557749. ... Journals to publish my research papers. kind regards Anthony. Reply. Dr. Sunny. July 13, 2022 at 3:32 am .
Choose the journal in which you want to publish the paper. Check the sample paper and "Instruction to Authors" or "Author's Guide" of that particular journal. Prepare your manuscript according to the format. Every journal article follows a specific format, such as Abstract, Introduction, Methods, Results, Discussion, Conclusion, and ...
Once you are done with the above mentioned steps, then you are eligible for writing a paper. 2. Read existing Papers. Read everything that might be relevant gives you different perspective of the focus topic. But be selective too, for not getting to much deviated from you topic of interest.
Elsevier Journal Finder helps you find journals that could be best suited for publishing your scientific article. Journal Finder uses smart search technology and field-of-research specific vocabularies to match your paper's abstract to scientific journals.
List of free publication journals indexed in Scopus, SCI. This web page aims to provide the latest list of free publication research journals. These journals are Web of Science and Scopus indexed. Moreover, all these scientific journals are open access. Researchers are advised to click on the journal title to know more journal details.
How to share your research article to increase the impact of your research " How to publish a paper in the Research Leap". Publishing guidelines for authors - The International Journal of Management Science and Business Administration - ISSN 1849-5664 (ONLINE) - ISSN 1849-5419 (PRINT) The journal is submitted by clicking on the SUBMIT YOUR PAPER icon
We are seeking an experienced and skilled writer to help us with writing a research paper for publication in an international journal. The paper should be related to computer science and aimed at securing admission into a foreign university. The ideal candidate should have a strong background in computer science and be familiar with the publishing process. It is important to have excellent ...
International Journal of Healthcare Sciences. ISSN 2348-5728 (Online) Vol. 12, Issue 1, April 2024 - September 2024. Page No: 114-128. Research Publish Journals. Website: www.researchpublish.com. Published Date: 02-September-2024
Automation does not remove the need for human involvement. It changes, and it can be reduced in some cases. Automation may lead to unforeseen impacts on systems' safety and productivity unless humans' role is carefully considered (Horberry et al., 2016a).Lessons from other industries, such as in aviation and medicine (where it is common), have been introduced with the belief that human ...
CALS is delighted to announce that our former Adjunct Senior Research Fellow (Apr 2023 - Apr 2024), Shamshad Pasarlay, has published his article, titled "Dialogic Incrementalism in Deeply Divided Societies", in the International Journal of Constitutional Law.Shamshad had worked on this piece of research during his stint with CALS.
The defossilisation of the agricultural sector is driven by intense worldwide academic research on non-fossil, renewable and energy-efficient agriculture, and the acknowledgment of the need for sustainable farming practices. For this purpose, not only technical transformations but also socio-technical system changes towards sustainability need to take place in a co-evolutionary manner. This ...
In 2023, the genetics scientific community celebrated two special anniversaries: the discovery of the double helix structure of DNA was published in 1953 and in 2003 the Human Genome Project was declared completed and made publicly available. To this day, genetics and genomics research is continuing to evolve at high pace and is identifying a steadily increasing number of genes as causal for ...